II. Epidemiology
- Rare: <500 cases reported in U.S. in the last 25 years
- Region
- U.S. West of the Mississippi River
- More common in mountains
III. Pathophysiology
- Cause
- Spirochetes in Borrelia genus
- Total of 18 Borrelia species causing Relapsing Fever (with all but 1 transmitted by tick)
- Vectors
- Soft Ticks (Ornithodoros genus)
- Other Borrelia species cause Relapsing Fever in Africa and Russia (e.g. B hispanica, B. duttonii)
- Borrelia Hermsii (reservoir: Squirrels and chipmunks in U.S. western mountains)
- Borrelia Turicate (reservoir: Cattle, rodents, pigs in south central and southwestern U.S.)
- Borrelia Miyamotoi (Northeast and Northern midwest)
- Body Lice (pediculus humanus, human to human transmission, only louse-borne Borrelia infection)
- Borrelia Recurrentis
- Soft Ticks (Ornithodoros genus)
- Exposure
- Mountain cabin with rodents
- Cave exploration
- Work under buidlings
- Relapsing Fever Pattern Mechanisms
IV. Symptoms (follows 7 day Incubation Period)
-
Fever
- Sudden onset, over 102.5 F (39.2 C)
- May rise over 104 F
- Pattern
- Fever for 3 to 6 days
- Febrile period ends with 30 minute crisis period
- Brief spike in pulse and Blood Pressure
- Sweats occur as the fever abates
- Fever recurs every 4 to 14 days (8 day average)
- Associated symptoms accompany Recurrent Fever and last 3-6 days per episode
- Interval between episodes lengthens overtime, with each recurrent episode trending to more mild
- Associated symptoms
- Headache
- Myalgias and Arthralgias
- Shaking Chills (rigors)
- Profuse diaphoresis (as fever resolves days 3 to 6)
- Nausea or Vomiting
- Abdominal Pain
V. Signs
- See Complications (below)
- Tachycardia
- Hypertension
- Hepatomegaly (10%)
- Splenomegaly (6%)
VI. Labs: Diagnosis
- Test Sensitivity is highest during febrile periods
- Immunofluorescence and PCR are not widely available
- Microscopic exam of blood, CSF other body fluid
- Thick and thin smears stained with Wright's or Giemsa (or dark microscopy)
- Spirochetes identified
-
Blood Cultures during febrile period
- Requires special media
VII. Labs: Other findings
-
Complete Blood Count
- Anemia
- Slight Leukocytosis
- Thrombocytopenia
-
Liver Function Tests
- Increased Unconjugated Bilirubin
- Increased Aminotransferases
-
Urinalysis
- Proteinuria and Hematuria
VIII. Labs: If indicated
-
Myocarditis suspected
- EKG with Prolonged QT interval (QTc)
-
Meningitis suspected
- CSF mononuclear Pleocytosis and increased CSF Protein
IX. Management
- Risk of Jarisch-Herxheimer Reaction with treatment (see below)
- Tick-Borne Infection
- Doxycycline 100 mg oral or IV twice daily for 7-10 days (preferred) OR
- Children: 4.4 mg/kg/day divided twice daily (up to 100 mg/dose)
- Erythromycin 500 mg orally qid for 7-10 days OR
- Penicillin G 5 MU IV every 6 hours for 7 to 10 days
- Doxycycline 100 mg oral or IV twice daily for 7-10 days (preferred) OR
- Louse-borne Infection
- Tetracycline 500 mg oral or IV once OR
- Erythromycin 500 mg oral or IV once
-
Central Nervous System Involvement
- Ceftriaxone IV OR
- Penicillin G IV
X. Complications
-
Jarisch-Herxheimer Reaction (54% of treated cases)
- Occurs with treatment of Spirochete disease (similar to Syphilis treatment)
- Onset within 2 hours of starting treatment
- Observe for 12 to 24 hours after starting treatment
- Neurologic
- Meningitis (2%)
- Encephalopathy
- Cranial Nerve palsy (e.g. Bell's Palsy, Deafness)
- Altered Level of Consciousness (Delirium, coma)
- Cardiopulmonary
- Acute Respiratory Distress Syndrome (ARDS)
- Pneumonitis
- Myocarditis
- Ocular
XI. Prognosis
- Mortality <1% in treated cases
- Poor prognostic factors
- Myocarditis
- Altered Level of Consciousness
- Poor liver function
- Bleeding complications from multiple sites
XII. Prevention
- See Prevention of Tick-borne Infection
- Spray susceptible buildings with Malathion 0.5%
- Keep home free of rodents
XIII. References
- (2025) Sanford Guide, accessed on 3/7/2025
- Dworkin (2002) Med Clin North Am 86:417-33 [PubMed]
- Pace (2020) Am Fam Physician 101(9): 530-40 [PubMed]
- Roscoe (2005) Am Fam Physician 72(10):2039-44 [PubMed]